Gibson C Michael, Murphy Sabina A, Morrow David A, Aroesty Julian M, Gibbons Raymond J, Gourlay Steven G, Barron Hal V, Giugliano Robert P, Antman Elliott M, Braunwald Eugene
TIMI Study Group, the Department of Medicine, Brigham & Women's Hospital, Boston, Mass., USA.
Am Heart J. 2004 Aug;148(2):336-40. doi: 10.1016/j.ahj.2003.12.044.
Both epicardial and myocardial perfusion have been associated with clinical outcomes in the setting of ST elevation myocardial infarction (STEMI), and the performance of adjunctive/rescue percutaneous coronary intervention (PCI) may further improve clinical outcomes after fibrinolytic administration.
The goal was to develop a simple, broadly applicable angiographic metric that takes into account indices of epicardial and myocardial perfusion both before and after PCI to arrive at a single perfusion grade in patients undergoing cardiac catheterization after fibrinolysis. The angiographic perfusion score (APS) is the sum of the Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG; 0-3) added to the TIMI myocardial perfusion grade (TMPG; 0-3) before and after PCI (total possible grade, 0-12). Failed perfusion was defined as an APS of 0 to 3, partial perfusion was defined as an APS of 4 to 9, and full perfusion was defined as an APS of 10 to 12. The APS was evaluated in patients from the Double-blind, Placebo-contolled, Multicenter Angiographic Trial of Rhumab CD18 in Acute Myocardial Infarction (LIMIT-AMI; n = 394) and Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction-Thrombolysis In Myocardial Infarction (ENTIRE-TIMI) 23 trials (n = 483), and infarct size (120-216 hours after AMI SPECT Technetium-99m Sestamibi data) was assessed in the LIMIT-AMI trial.
The APS was associated with the incidence of death or myocardial infarction (failed, 16.7% [n = 18]; partial, 2.5% [n = 155]; full, 2.4% [n = 82]; P =.039 for trend) and larger SPECT infarct sizes (failed, median 39% [n = 10]; partial, 12% [n = 79]; and full, 8% [n = 35]; P =.002). No patient with full APS died, whereas the mortality rate was 11.1% in patients with a failed APS (P =.03).
The APS combines grades of epicardial and tissue level perfusion before and after PCI or at the end of diagnostic cardiac catheterization to arrive at a single angiographic variable that is associated with infarct size and the rates of 30-day death or MI. Partial or full angiographic perfusion scores are associated with a halving of infarct size, and no patients with full angiographic perfusion died.
在ST段抬高型心肌梗死(STEMI)患者中,心外膜和心肌灌注均与临床结局相关,辅助/挽救性经皮冠状动脉介入治疗(PCI)的实施可能会进一步改善溶栓治疗后的临床结局。
目标是开发一种简单、广泛适用的血管造影指标,该指标考虑PCI前后的心外膜和心肌灌注指标,以便为溶栓后接受心导管检查的患者得出单一灌注等级。血管造影灌注评分(APS)是心肌梗死溶栓(TIMI)血流分级(TFG;0 - 3)与PCI前后的TIMI心肌灌注分级(TMPG;0 - 3)之和(总可能等级为0 - 12)。灌注失败定义为APS为0至3,部分灌注定义为APS为4至9,完全灌注定义为APS为10至12。在急性心肌梗死中使用抗CD18单抗的双盲、安慰剂对照、多中心血管造影试验(LIMIT - AMI;n = 394)和依诺肝素作为ST段抬高型心肌梗死溶栓治疗的辅助抗凝血酶治疗 - TIMI 23试验(ENTIRE - TIMI;n = 483)的患者中评估APS,并在LIMIT - AMI试验中评估梗死面积(急性心肌梗死后120 - 216小时的锝 - 99m甲氧基异丁基异腈单光子发射计算机断层扫描数据)。
APS与死亡或心肌梗死发生率相关(灌注失败,16.7% [n = 18];部分灌注,2.5% [n = 155];完全灌注,2.4% [n = 82];趋势P = 0.039)以及更大的单光子发射计算机断层扫描梗死面积(灌注失败,中位数39% [n = 10];部分灌注,12% [n = 79];完全灌注,8% [n = 35];P = 0.002)。没有完全APS的患者死亡,而APS失败的患者死亡率为11.1%(P = 0.03)。
APS结合了PCI前后或诊断性心导管检查结束时的心外膜和组织水平灌注等级,得出一个与梗死面积以及30天死亡或心肌梗死发生率相关的单一血管造影变量。部分或完全血管造影灌注评分与梗死面积减半相关,且没有完全血管造影灌注的患者死亡。